Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'interindividual variability' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 116 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dufour, E; Gerdeaux, D; Corvi, C; Khim-Heang, S; Mariotti, A
      Assessment of the contaminant concentration variability among Lake Geneva arctic char using stable isotopic composition (delta N-15 and delta C-13)

      ENVIRONMENTAL TOXICOLOGY
    2. Licata, AC; Dekant, W; Smith, CE; Borghoff, SJ
      A physiologically based pharmacokinetic model for methyl tert-butyl ether in humans: Implementing sensitivity and variability analyses

      TOXICOLOGICAL SCIENCES
    3. Vermeulen, NPE; van Bladeren, PJ
      Trichloroethylene risk assessment: Relevance of interindividual differences

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    4. Abdel-Megeed, MA; Suh, DH; Abdel-Rahman, MS
      Intra-species extrapolation in risk assessment of different classes of antimicrobials

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    5. Marien, K; Patrick, GM
      Exposure analysis of five fish-consuming populations for overexposure to methylmercury

      JOURNAL OF EXPOSURE ANALYSIS AND ENVIRONMENTAL EPIDEMIOLOGY
    6. Crasson, M; Lembreghts, M; El Ahmadi, A; Legros, JJ; Timsit-Berthier, M
      Interindividual variability of negative contingent variation (CNV).

      NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    7. Cok, I; Kocabas, NA; Cholerton, S; Karakaya, AE; Sardas, S
      Determination of coumarin metabolism in Turkish population

      HUMAN & EXPERIMENTAL TOXICOLOGY
    8. Finelli, LA; Achermann, P; Borbely, AA
      Individual "fingerprints" in human sleep EEG topography

      NEUROPSYCHOPHARMACOLOGY
    9. Guyomarc'h, C; Lumineau, S; Vivien-Roels, B; Richard, JP; Deregnaucourt, S
      Effect of melatonin supplementation on the sexual development in European quail (Coturnix coturnix)

      BEHAVIOURAL PROCESSES
    10. Boulton, DW; Arnaud, P; DeVane, CL
      A single dose of methadone inhibits cytochrome P-4503A activity in healthyvolunteers as assessed by the urinary cortisol ratio

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    11. Hattis, D; Russ, A; Goble, R; Banati, P; Chu, M
      Human interindividual variability in susceptibility to airborne particles

      RISK ANALYSIS
    12. Rabovsky, J; Fowles, J; Hill, MD; Lewis, DC
      A health risk benchmark for the neurologic effects of styrene: Comparison with NOAEL/LOAEL approach

      RISK ANALYSIS
    13. Eap, CB; Broly, F; Mino, A; Hammig, R; Deglon, JJ; Uehlinger, C; Meili, D; Chevalley, AF; Bertschy, G; Zullino, D; Kosel, M; Preisig, M; Baumann, P
      Cytochrome P450 2D6 genotype and methadone steady-state concentrations

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    14. Tyndale, RF; Sellers, EM
      Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk

      DRUG METABOLISM AND DISPOSITION
    15. Vietri, M; Pietrabissa, A; Mosca, F; Rane, A; Pacifici, GM
      Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid

      XENOBIOTICA
    16. Hoekema, R; Uijen, GJH; van Oosterom, A
      Geometrical aspects of the interindividual variability of multilead ECG recordings

      IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
    17. Boulton, DW; Arnaud, P; DeVane, CL
      Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    18. Auffray, C; Juhel, J
      General and differential effects of a multimodal cognitive training program for the eldenly.

      ANNEE PSYCHOLOGIQUE
    19. Mertens, MJ; Vuyk, J; Olofsen, E; Bovill, JG; Burm, AGL
      Propofol alters the pharmacokinetics of alfentanil in healthy male volunteers

      ANESTHESIOLOGY
    20. Eap, CB
      On the usefulness of therapeutic drug monitoring of methadone

      EUROPEAN ADDICTION RESEARCH
    21. Nowell, S; Ambrosone, CB; Ozawa, S; MacLeod, SL; Mrackova, G; Williams, S; Plaxco, J; Kadlubar, FF; Lang, NP
      Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol

      PHARMACOGENETICS
    22. Ariyoshi, N; Takahashi, Y; Miyamoto, M; Umetsu, Y; Daigo, S; Tateishi, T; Kobayashi, S; Mizorogi, Y; Loriot, MA; Stucker, I; Beaune, P; Kinoshita, M; Kamataki, T
      Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C

      PHARMACOGENETICS
    23. Fisher, MB; VandenBranden, M; Findlay, K; Burchell, B; Thummel, KE; Hall, SD; Wrighton, SA
      Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank

      PHARMACOGENETICS
    24. Helton, JC; Anderson, DR; Basabilvazo, G; Jow, HN; Marietta, MG
      Conceptual structure of the 1996 performance assessment for the Waste Isolation Pilot Plant

      RELIABILITY ENGINEERING & SYSTEM SAFETY
    25. Oswald, WD
      Are age and aging measurable?

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    26. Boulton, DW; Devane, CL
      Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadone

      CHIRALITY
    27. Van Landuyt, LM; Ekkekakis, P; Hall, EE; Petruzzello, SJ
      Throwing the mountains into the lakes: On the perils of nomothetic conceptions of the exercise-affect relationship

      JOURNAL OF SPORT & EXERCISE PSYCHOLOGY
    28. Virgili, F; Pagana, G; Bourne, L; Rimbach, G; Natella, F; Rice-Evans, C; Packer, L
      Ferulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extract

      FREE RADICAL BIOLOGY AND MEDICINE
    29. Eap, CB; Bourquin, M; Martin, JL; Spagnoli, J; Livoti, S; Powell, K; Baumann, P; Deglon, JJ
      Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment

      DRUG AND ALCOHOL DEPENDENCE
    30. Bourian, M; Gullsten, H; Legrum, W
      Genetic polymorphism of CYP2A6 in the German population

      TOXICOLOGY
    31. Pelkonen, O; Rautio, A; Raunio, H; Pasanen, M
      CYP2A6: a human coumarin 7-hydroxylase

      TOXICOLOGY
    32. Zabetian, CP; Gelernter, J; Cubells, JF
      Functional variants at CYP2A6: New genotyping methods, population genetics, and relevance to studies of tobacco dependence

      AMERICAN JOURNAL OF MEDICAL GENETICS
    33. Barbier, O; Turgeon, D; Girard, C; Green, MD; Tephly, TR; Hum, DW; Belanger, A
      3 '-azido-3 '-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7)

      DRUG METABOLISM AND DISPOSITION
    34. Kharasch, ED; Hankins, DC; Taraday, JK
      Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity

      DRUG METABOLISM AND DISPOSITION
    35. Vietri, M; Pietrabissa, A; Mosca, F; Pacifici, GM
      Mycophenolic acid glucuronidation and its inhibition by non-steroidal anti-inflammatory drugs in human liver and kidney

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    36. Vietri, M; Pietrabissa, A; Spisni, R; Mosca, F; Pacifici, GM
      Differential inhibition of hepatic and duodenal sulfation of (-)-salbutamol and minoxidil by mefenamic acid

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    37. Waters, CM; Krejcie, TC; Avram, MJ
      Facilitated uptake of fentanyl, but not alfentanil, by human pulmonary endothelial cells

      ANESTHESIOLOGY
    38. Laurell, G; Viberg, A; Teixeira, M; Sterkers, O; Ferrary, E
      Blood-perilymph barrier and ototoxicity: An in vivo study in the rat

      ACTA OTO-LARYNGOLOGICA
    39. Ortelli, D; Rudaz, S; Chevalley, AF; Mino, A; Deglon, JJ; Balant, L; Veuthey, JL
      Enantioselective analysis of methadone in saliva by liquid chromatography-mass spectrometry

      JOURNAL OF CHROMATOGRAPHY A
    40. Perera, FP
      Molecular epidemiology: On the path to prevention?

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    41. Testard, I; Sabatier, L
      Biological dosimetry for astronauts: a real challenge

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    42. Atanasova, I; Bozhinova, K; Terziivanov, D
      Average bioequivalence of two oral formulations of fluconazole in healthy subjects after multiple dosing

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    43. Bourian, M; Runkel, M; Krisp, A; Tegtmeier, M; Freudenstein, J; Legrum, W
      Naringenin and interindividual variability in interaction of coumarin withgrapefruit juice

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    44. Felder, C; Uehlinger, C; Baumann, P; Powell, K; Eap, CB
      Oral and intravenous methadone use: some clinical and pharmacokinetic aspects

      DRUG AND ALCOHOL DEPENDENCE
    45. de Wildt, SN; Kearns, GL; Leeder, JS; van den Anker, JN
      Cytochrome P450 3A - Ontogeny and drug disposition

      CLINICAL PHARMACOKINETICS
    46. Maxwell, S; Shinderman, M
      Optimizing response to methadone maintenance treatment: Use of higher-dosemethadone

      JOURNAL OF PSYCHOACTIVE DRUGS
    47. Dybing, E; Soderlund, EJ
      Situations with enhanced chemical risks due to toxicokinetic and toxicodynamic factors

      REGULATORY TOXICOLOGY AND PHARMACOLOGY
    48. Manca, D; Walker, RM; Krishna, G; Graziano, MJ; Kropko, ML
      Probabilistic approach to the establishment of maximal content limits of impurities in drug formulations: The case of parenteral diphenylhydantoic acid

      REGULATORY TOXICOLOGY AND PHARMACOLOGY
    49. Frey, HC; Burmaster, DE
      Methods for characterizing variability and uncertainty: Comparison of bootstrap simulation and likelihood-based approaches

      RISK ANALYSIS
    50. Amodio, P; Del Piccolo, F; Marchetti, P; Angeli, P; Iemmolo, R; Caregaro, L; Merkel, C; Gerunda, G; Gatta, A
      Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

      HEPATOLOGY
    51. Balant-Gorgia, AE; Gex-Fabry, M; Genet, C; Balant, LP
      Therapeutic drug monitoring of risperidone using a new, rapid HPLC method:Reappraisal of interindividual variability factors

      THERAPEUTIC DRUG MONITORING
    52. Parmigiani, S; Palanza, P; Rodgers, J; Ferrari, PF
      Selection, evolution of behavior and animal models in behavioral neuroscience

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    53. Calderon, RL; Hudgens, E; Le, XC; Schreinemachers, D; Thomas, DJ
      Excretion of arsenic in urine as a function of exposure to arsenic in drinking water

      ENVIRONMENTAL HEALTH PERSPECTIVES
    54. Gibbs, MA; Thummel, KE; Shen, DD; Kunze, KL
      Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: Comparison of K-I values and impact of CYP3A5 expression

      DRUG METABOLISM AND DISPOSITION
    55. Hong, JY; Wang, YY; Bondoc, FY; Lee, M; Yang, CS; Hu, WY; Pan, JM
      Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterologously expressed human cytochromes P450: Identification of CYP2A6 as a major catalyst

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    56. Jacobsen, W; Kirchner, G; Hallensleben, K; Mancinelli, L; Deters, M; Hackbarth, I; Baner, K; Benet, LZ; Sewing, KF; Christians, U
      Small intestinal metabolism of the 3-hydroxy-3-methylglutary-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    57. Nunoya, K; Yokoi, T; Kimura, K; Kainuma, T; Satoh, K; Kinoshita, M; Kamataki, T
      A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride inhumans

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    58. Quester, R; Schroder, R
      Topographic anatomy of the cochlear nuclear region at the floor of the fourth ventricle in humans

      JOURNAL OF NEUROSURGERY
    59. Hoekema, R; Uijen, GJH; van Erning, L; van Oosterom, A
      Interindividual variability of multilead electrocardiographic recordings -Influence of heart position

      JOURNAL OF ELECTROCARDIOLOGY
    60. Nunoya, K; Yokoi, T; Takahashi, Y; Kimura, K; Kinoshita, M; Kamataki, T
      Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype

      JOURNAL OF BIOCHEMISTRY
    61. Oscarson, M; McLellan, RA; Gullsten, H; Agundez, JAG; Benitez, J; Rautio, A; Raunio, H; Pelkonen, O; Ingelman-Sundberg, M
      Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

      FEBS LETTERS
    62. Oscarson, M; McLellan, RA; Gullsten, H; Yue, QY; Lang, MA; Bernal, ML; Sinues, B; Hirvonen, A; Raunio, H; Pelkonen, O; Ingelman-Sundberg, M
      Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population

      FEBS LETTERS
    63. Kitagawa, K; Kunugita, N; Katoh, T; Yang, MH; Kawamoto, T
      The significance of the homozygous CYP2A6 deletion on nicotine metabolism:A new genotyping method of CYP2A6 using a single PCR-RFLP

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    64. Miyamoto, M; Umetsu, Y; Dosaka-Akita, H; Sawamura, Y; Yokota, J; Kunitoh, H; Nemoto, N; Sato, K; Ariyoshi, N; Kamataki, T
      CYP2A6 gene deletion reduces susceptibility to lung cancer

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    65. Albrecht, S; Ihmsen, H; Suchodolski, K; Frenkel, C; Schuttler, J
      Analgo-sedation in intensive care: a quantitative, EEG-based trial with propofol 1% and 2%

      ANAESTHESIST
    66. Barbeau, P; Gutin, B; Litaker, M; Owens, S; Riggs, S; Okuyama, T
      Correlates of individual differences in body-composition changes resultingfrom physical training in obese children

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    67. FREY HC; RHODES DS
      CHARACTERIZATION AND SIMULATION OF UNCERTAIN FREQUENCY-DISTRIBUTIONS - EFFECTS OF DISTRIBUTION CHOICE, VARIABILITY, UNCERTAINTY, AND PARAMETER DEPENDENCE

      Human and ecological risk assessment
    68. BARTON HA; ANDERSEN ME
      ENDOCRINE ACTIVE COMPOUNDS - FROM BIOLOGY TO DOSE-RESPONSE ASSESSMENT

      Critical reviews in toxicology
    69. NUNOYA K; YOKOI T; KIMURA K; INOUE K; KODAMA T; FUNAYAMA M; NAGASHIMA K; FUNAE Y; GREEN C; KINOSHITA M; KAMATAKI T
      A NEW DELETED ALLELE IN THE HUMAN CYTOCHROME-P450 2A6 (CYP2A6) GENE FOUND IN INDIVIDUALS SHOWING POOR METABOLIC CAPACITY TO COUMARIN AND (-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE (SM-12502)())

      Pharmacogenetics
    70. TILLMANN B; KRUMPELMANN S; WURTHWEIN G; WAGNER A; SCHULZEWESTHOFF P; HEMPEL G; JURGENS H; BOOS J
      PHARMACOKINETIC ASPECTS OF ORAL ETOPOSIDE

      Klinische Padiatrie
    71. REDAELLI A; MAGRASSI R; BONASSI S; ABBONDANDOLO A; FROSINA G
      AP ENDONUCLEASE ACTIVITY IN HUMANS - DEVELOPMENT OF A SIMPLE ASSAY AND ANALYSIS OF 10 NORMAL INDIVIDUALS

      Teratogenesis, carcinogenesis, and mutagenesis
    72. CARACO Y
      GENETIC-DETERMINANTS OF DRUG RESPONSIVENESS AND DRUG-INTERACTIONS

      Therapeutic drug monitoring
    73. MCFADDEN JP; WAKELIN SH; HOLLOWAY DB; BASKETTER DA
      THE EFFECT OF PATCH DURATION ON THE ELICITATION OF PARA-PHENYLENEDIAMINE CONTACT ALLERGY

      Contact dermatitis
    74. HADIDI H; IRSHAID Y; VAGBO CB; BRUNSVIK A; CHOLERTON S; ZAHLSEN K; IDLE JR
      VARIABILITY OF COUMARIN 7-HYDROXYLATION AND 3-HYDROXYLATION IN A JORDANIAN POPULATION IS SUGGESTIVE OF A FUNCTIONAL POLYMORPHISM IN CYTOCHROME-P450 CYP2A6

      European Journal of Clinical Pharmacology
    75. LAMPEN A; ZHANG YC; HACKBARTH I; BENET LZ; SEWING KF; CHRISTIANS U
      METABOLISM AND TRANSPORT OF THE MACROLIDE IMMUNOSUPPRESSANT SIROLIMUSIN THE SMALL-INTESTINE

      The Journal of pharmacology and experimental therapeutics
    76. OSCARSON M; GULLSTEN H; RAUTIO A; BERNAL ML; SINUES B; DAHL ML; STENGARD JH; PELKONEN O; RAUNIO H; INGELMANSUNDBERG M
      GENOTYPING OF HUMAN CYTOCHROME-P450 2A6 (CYP2A6), A NICOTINE C-OXIDASE

      FEBS letters
    77. HATTIS D
      HUMAN VARIABILITY IN SUSCEPTIBILITY - HOW BIG, HOW OFTEN, FOR WHAT RESPONSES TO WHAT AGENTS

      Environmental toxicology and pharmacology
    78. BECK BD
      THE USE OF INFORMATION ON SUSCEPTIBILITY IN RISK ASSESSMENT - STATE OF THE SCIENCE AND POTENTIAL FOR IMPROVEMENT

      Environmental toxicology and pharmacology
    79. FRAME LT; GATLIN TL; KADLUBAR FF; LANG NP
      METABOLIC DIFFERENCES AND THEIR IMPACT ON HUMAN-DISEASE - SULFOTRANSFERASE AND COLORECTAL-CANCER

      Environmental toxicology and pharmacology
    80. BILLARD V; CAZALAA JB; SERVIN F; VIVIAN X
      TARGET-CONTROLLED INTRAVENOUS ANESTHESIA

      Annales francaises d'anesthesie et de reanimation
    81. HAIGH JM; MEYER E; SMITH EW; KANFER I
      THE HUMAN SKIN BLANCHING ASSAY FOR IN-VIVO TOPICAL CORTICOSTEROID ASSESSMENT .2. SUBJECT-DEPENDENT AND OBSERVER-DEPENDENT VARIATION IN BLANCHING RESPONSES

      International journal of pharmaceutics
    82. PASANEN M; RANNALA Z; TOOMING A; SOTANIEMI EA; PELKONEN O; RAUTIO A
      HEPATITIS-A IMPAIRS THE FUNCTION OF HUMAN HEPATIC CYP2A6 IN-VIVO

      Toxicology
    83. MARINI M; URBANI A; TRANI E; BONGIORNO L; RODA LG
      INTERINDIVIDUAL VARIABILITY OF ENKEPHALIN-DEGRADING ENZYMES IN HUMAN PLASMA

      Peptides
    84. GOBBA F; ROVESTI S; BORELLA P; VIVOLI R; CASELGRANDI E; VIVOLI G
      INTERINDIVIDUAL VARIABILITY OF BENZENE METABOLISM TO TRANS,TRANS-MUCONIC ACID AND ITS IMPLICATIONS IN THE BIOLOGICAL MONITORING OF OCCUPATIONAL EXPOSURE

      Science of the total environment
    85. GUITTON J; BURONFOSSE T; DESAGE M; LEPAPE A; BRAZIER JL; BEAUNE P
      POSSIBLE INVOLVEMENT OF MULTIPLE CYTOCHROME P450S IN FENTANYL AND SUFENTANIL METABOLISM AS OPPOSED TO ALFENTANIL

      Biochemical pharmacology
    86. FERRARI PF; PARMIGIANI S; RODGERS RJ; PALANZA P
      DIFFERENTIAL-EFFECTS OF CHLORDIAZEPOXIDE ON AGGRESSIVE-BEHAVIOR IN MALE-MICE - THE INFLUENCE OF SOCIAL-FACTORS

      Psychopharmacology
    87. BOGAN DP; OKENNEDY R
      SIMULTANEOUS DETERMINATION OF COUMARIN, 7-HYDROXYCOUMARIN AND 7-HYDROXYCOUMARIN GLUCURONIDE IN HUMAN SERUM AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical applications
    88. RENWICK AG; HATTIS D
      INTRODUCTION TO THE WORKSHOP ON VARIABILITY IN TOXIC RESPONSE - HUMANAND ENVIRONMENTAL - RAPPORTEURS SUMMARY

      Environmental toxicology and pharmacology
    89. HATTIS D
      VARIABILITY IN SUSCEPTIBILITY - HOW BIG, HOW OFTEN FOR WHAT RESPONSESTO WHAT AGENTS

      Environmental toxicology and pharmacology
    90. DEPLEDGE MH; LUNDEBYE AK
      PHYSIOLOGICAL MONITORING OF CONTAMINANT EFFECTS IN INDIVIDUAL ROCK CRABS, HEMIGRAPSUS-EDWARDSI - THE ECOTOXICOLOGICAL SIGNIFICANCE OF VARIABILITY IN RESPONSE

      Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology
    91. HELTON JC; BURMASTER DE
      GUEST EDITORIAL - TREATMENT OF ALEATORY AND EPISTEMIC UNCERTAINTY IN PERFORMANCE ASSESSMENTS FOR COMPLEX-SYSTEMS

      Reliability engineering & systems safety
    92. KILLARD AJ; OKENNEDY R; BOGAN DP
      ANALYSIS OF THE GLUCURONIDATION OF 7-HYDROXYCOUMARIN BY HPLC

      Journal of pharmaceutical and biomedical analysis
    93. LEVIN LE
      PASSAGE ORDER THROUGH DIFFERENT PATHWAYS IN GROUPS OF SCHOOLING FISH,AND THE DIVERSIFIED LEADERSHIP HYPOTHESIS

      Behavioural processes
    94. GRASSMAN JA
      OBTAINING INFORMATION ABOUT SUSCEPTIBILITY FROM THE EPIDEMIOLOGIC LITERATURE

      Toxicology
    95. BARTON HA; FLEMMING CD; LIPSCOMB JC
      EVALUATING HUMAN VARIABILITY IN CHEMICAL RISK ASSESSMENT - HAZARD IDENTIFICATION AND DOSE-RESPONSE ASSESSMENT FOR NONCANCER ORAL TOXICITY OF TRICHLOROETHYLENE

      Toxicology
    96. CLEWELL HJ; ANDERSEN ME
      USE OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO INVESTIGATE INDIVIDUAL VERSUS POPULATION RISK

      Toxicology
    97. CURTIN F; WALKER JP; SCHULZ P
      DAY-TO-DAY INTRAINDIVIDUAL RELIABILITY AND INTERINDIVIDUAL DIFFERENCES IN MONOAMINES EXCRETION

      Journal of affective disorders
    98. JACOLOT A; TOD M; HEUDES AM; PETITJEAN O; LAROCHE L
      MONITORING OF 8-METHOXYPSORALEN DURING EXTRACORPOREAL PHOTOCHEMOTHERAPY - EVIDENCE FOR A FIRST-DOSE EFFECT

      Therapeutic drug monitoring
    99. HATTIS D; GLOWA J; TILSON H; ULBRICH B
      RISK ASSESSMENT FOR NEUROBEHAVIORAL TOXICITY - SGOMSEC JOINT REPORT

      Environmental health perspectives
    100. TRANSON C; LECOEUR S; LEEMANN T; BEAUNE P; DAYER P
      INTERINDIVIDUAL VARIABILITY IN CATALYTIC ACTIVITY AND IMMUNOREACTIVITY OF 3 MAJOR HUMAN LIVER CYTOCHROME-P450 ISOZYMES

      European Journal of Clinical Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 00:18:12